iRhythm Technologies Net Income
| IRTC Stock | USD 148.50 2.03 1.39% |
As of the 10th of February, IRhythm Technologies retains the Standard Deviation of 2.69, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of (0.26). IRhythm Technologies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
IRhythm Technologies Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 6.9558 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -102 M | -96.9 M | |
| Net Loss | -102 M | -96.9 M | |
| Net Loss | -104.5 M | -99.3 M | |
| Net Loss | (3.27) | (3.43) | |
| Net Income Per E B T | 0.90 | 0.80 |
IRhythm | Net Income | Build AI portfolio with IRhythm Stock |
Analyzing IRhythm Technologies's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing IRhythm Technologies's current valuation and future prospects.
Latest IRhythm Technologies' Net Income Growth Pattern
Below is the plot of the Net Income of iRhythm Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in iRhythm Technologies financial statement analysis. It represents the amount of money remaining after all of iRhythm Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is IRhythm Technologies' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRhythm Technologies' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (113.29 M) | 10 Years Trend |
|
Net Income |
| Timeline |
IRhythm Net Income Regression Statistics
| Arithmetic Mean | (55,614,070) | |
| Coefficient Of Variation | (76.94) | |
| Mean Deviation | 37,570,444 | |
| Median | (43,830,000) | |
| Standard Deviation | 42,789,493 | |
| Sample Variance | 1830.9T | |
| Range | 109.8M | |
| R-Value | (0.91) | |
| Mean Square Error | 342.2T | |
| R-Squared | 0.82 | |
| Slope | (7,695,410) | |
| Total Sum of Squares | 29295.1T |
IRhythm Net Income History
Other Fundumenentals of iRhythm Technologies
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
IRhythm Technologies Net Income component correlations
IRhythm Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for IRhythm Technologies is extremely important. It helps to project a fair market value of IRhythm Stock properly, considering its historical fundamentals such as Net Income. Since IRhythm Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IRhythm Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IRhythm Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could IRhythm diversify its offerings? Factors like these will boost the valuation of IRhythm Technologies. Market participants price IRhythm higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IRhythm Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.61) | Revenue Per Share | Quarterly Revenue Growth 0.307 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, IRhythm Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
IRhythm Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRhythm Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRhythm Technologies.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in IRhythm Technologies on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding iRhythm Technologies or generate 0.0% return on investment in IRhythm Technologies over 90 days. IRhythm Technologies is related to or competes with Bruker, Glaukos Corp, BrightSpring Health, RadNet, Chemed Corp, Crispr Therapeutics, and Vaxcyte. iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for ... More
IRhythm Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRhythm Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iRhythm Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 13.25 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 4.78 |
IRhythm Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRhythm Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRhythm Technologies' standard deviation. In reality, there are many statistical measures that can use IRhythm Technologies historical prices to predict the future IRhythm Technologies' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IRhythm Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
IRhythm Technologies February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | (1,015) | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.21 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 13.25 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 4.78 | |||
| Skewness | (0.26) | |||
| Kurtosis | 0.6877 |
iRhythm Technologies Backtested Returns
iRhythm Technologies holds Efficiency (Sharpe) Ratio of -0.0979, which attests that the entity had a -0.0979 % return per unit of risk over the last 3 months. iRhythm Technologies exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IRhythm Technologies' Risk Adjusted Performance of (0.07), standard deviation of 2.69, and Market Risk Adjusted Performance of (0.26) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.0, which attests to a somewhat significant risk relative to the market. IRhythm Technologies returns are very sensitive to returns on the market. As the market goes up or down, IRhythm Technologies is expected to follow. At this point, iRhythm Technologies has a negative expected return of -0.27%. Please make sure to check out IRhythm Technologies' skewness, and the relationship between the total risk alpha and rate of daily change , to decide if iRhythm Technologies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
iRhythm Technologies has very weak reverse predictability. Overlapping area represents the amount of predictability between IRhythm Technologies time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iRhythm Technologies price movement. The serial correlation of -0.02 indicates that only 2.0% of current IRhythm Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 162.35 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
IRhythm Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, iRhythm Technologies reported net income of (113.29 Million). This is 133.2% lower than that of the Health Care Equipment & Supplies sector and 147.58% lower than that of the Health Care industry. The net income for all United States stocks is 119.84% higher than that of the company.
IRhythm Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IRhythm Technologies' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IRhythm Technologies could also be used in its relative valuation, which is a method of valuing IRhythm Technologies by comparing valuation metrics of similar companies.IRhythm Technologies is currently under evaluation in net income category among its peers.
IRhythm Technologies Current Valuation Drivers
We derive many important indicators used in calculating different scores of IRhythm Technologies from analyzing IRhythm Technologies' financial statements. These drivers represent accounts that assess IRhythm Technologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of IRhythm Technologies' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.7B | 6.6B | 3.5B | 2.8B | 2.5B | 1.6B | |
| Enterprise Value | 1.8B | 6.6B | 3.4B | 2.9B | 2.6B | 1.6B |
IRhythm Technologies ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IRhythm Technologies' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IRhythm Technologies' managers, analysts, and investors.Environmental | Governance | Social |
IRhythm Technologies Institutional Holders
Institutional Holdings refers to the ownership stake in IRhythm Technologies that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of IRhythm Technologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IRhythm Technologies' value.| Shares | Champlain Investment Partners, Llc | 2025-06-30 | 661.2 K | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 607.7 K | Fuller & Thaler Asset Management Inc | 2025-06-30 | 586.5 K | Bessemer Group Inc | 2025-06-30 | 569.2 K | Jpmorgan Chase & Co | 2025-06-30 | 563.2 K | Stephens Inv Mgmt Group Llc | 2025-06-30 | 552.9 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 434.3 K | Fmr Inc | 2025-06-30 | 420.2 K | Wellington Management Company Llp | 2025-06-30 | 395.3 K | Vanguard Group Inc | 2025-06-30 | 3.2 M | Sands Capital Management, Llc | 2025-06-30 | 2.9 M |
IRhythm Fundamentals
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.0308 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 4.89 B | ||||
| Shares Outstanding | 32.22 M | ||||
| Shares Owned By Insiders | 0.67 % | ||||
| Shares Owned By Institutions | 99.33 % | ||||
| Number Of Shares Shorted | 2.75 M | ||||
| Price To Earning | (36.08) X | ||||
| Price To Book | 38.72 X | ||||
| Price To Sales | 6.72 X | ||||
| Revenue | 591.84 M | ||||
| Gross Profit | 494.26 M | ||||
| EBITDA | (74.13 M) | ||||
| Net Income | (113.29 M) | ||||
| Cash And Equivalents | 204.49 M | ||||
| Cash Per Share | 6.81 X | ||||
| Total Debt | 736.91 M | ||||
| Debt To Equity | 0.54 % | ||||
| Current Ratio | 4.05 X | ||||
| Book Value Per Share | 3.79 X | ||||
| Cash Flow From Operations | 3.39 M | ||||
| Short Ratio | 4.61 X | ||||
| Earnings Per Share | (1.61) X | ||||
| Target Price | 221.27 | ||||
| Number Of Employees | 2 K | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 4.72 B | ||||
| Total Asset | 931.45 M | ||||
| Retained Earnings | (758.89 M) | ||||
| Working Capital | 534.9 M | ||||
| Current Asset | 54.91 M | ||||
| Current Liabilities | 11.97 M | ||||
| Net Asset | 931.45 M |
About IRhythm Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iRhythm Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IRhythm Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iRhythm Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:Check out For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Health Care Equipment & Supplies sector continue expanding? Could IRhythm diversify its offerings? Factors like these will boost the valuation of IRhythm Technologies. Market participants price IRhythm higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IRhythm Technologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.61) | Revenue Per Share | Quarterly Revenue Growth 0.307 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, IRhythm Technologies' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.